Clinical characteristics and human leukocyte antigens in patients with immune checkpoint inhibitor-induced type 1 diabetes and pituitary dysfunction: a single center prospective study.
Natsuko HaraHirotsugu SuwanaiFumiyoshi YakouKeitaro IshiiHajime IwasakiHironori AbeJumpei ShikumaHiroyuki SakaiTakashi MiwaRyo SuzukiPublished in: Endocrine (2023)
This study revealed the clinical characteristics of ICI-T1D and ICI-PD and the association between specific HLAs and these adverse events.